Which has grown faster, ELV or MRNA?

Over the past five years, MRNA grew revenue faster — ELV at a 9.25% CAGR versus MRNA at 19.33%.

Does ELV or MRNA pay a bigger dividend?

ELV pays a dividend (1.72% yield), while MRNA has no payments in the available dividend history.

Is ELV or MRNA more profitable?

ELV runs the higher net margin — ELV at 2.47% versus MRNA at -141.43%.

How have ELV and MRNA total returns compared?

Over the past 5 years, ELV delivered 13.46% and MRNA delivered -14.22% annualized total return. Past performance doesn't predict future results.

Elevance Health Inc. (ELV) vs Moderna, Inc. (MRNA)

A side-by-side comparison of Elevance Health Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

ELV

Elevance Health Inc.

$86.41B

$398.45HealthcareAt close: Aug 19, 2026, 4:00 PM ET

MRNA

Moderna, Inc.

$69.19B

$174.38HealthcareAt close: Aug 19, 2026, 4:00 PM ET

Total return — ELV vs MRNA

growth of $100 · dividends reinvested · last 8y

ELV +53.7% (+5.5%/yr)MRNA +837.5% (+32.3%/yr)MRNA compounded faster over this window

Log scale — wide-divergence pair

ELV MRNA

ELV vs MRNA: by the numbers

•ELV is the larger company ($86.41B vs $69.19B market cap).
•ELV is profitable (2.47% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 9.25% CAGR).
•ELV pays a dividend (1.72% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ELV	MRNA
P/E ratio	17.71	N/A
Forward P/E	14.68	N/A
P/S ratio	0.43	30.99
P/B ratio	1.93	10.21
EV / EBITDA	13.33	N/A
FCF yield	7.24%	N/A

Profitability

Metric	ELV	MRNA
Gross margin	25.56%	55.35%
Operating margin	3.51%	-158.13%
Net margin	2.47%	-141.43%
ROE	11.06%	-46.61%
ROIC	6.34%	-39.16%

Dividends

Metric	ELV	MRNA
Dividend yield	1.72%	N/A
Payout ratio	27.24%	N/A

Growth (annualized)

Metric	ELV	MRNA
Revenue CAGR (5Y)	9.25%	19.33%
EPS CAGR (5Y)	6.67%	N/A
FCF CAGR (5Y)	-19.97%	N/A
Total return CAGR (5Y)	2.64%	-14.22%

Frequently asked

Which has grown faster, ELV or MRNA?: Over the past five years, MRNA grew revenue faster — ELV at a 9.25% CAGR versus MRNA at 19.33%.
Does ELV or MRNA pay a bigger dividend?: ELV pays a dividend (1.72% yield), while MRNA has no payments in the available dividend history.
Is ELV or MRNA more profitable?: ELV runs the higher net margin — ELV at 2.47% versus MRNA at -141.43%.
How have ELV and MRNA total returns compared?: Over the past 5 years, ELV delivered 13.46% and MRNA delivered -14.22% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ELV analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Elevance Health P/E ratio Elevance Health dividend yield Elevance Health ROE Moderna ROE Elevance Health operating margin Moderna operating margin Elevance Health revenue growth Moderna revenue growth Elevance Health free cash flow Moderna free cash flow

Elevance Health & Moderna appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.